SCHEMBL21296540

SCHEMBL21296540

Cc1cccc(C2=CC[C@H](NC(=O)O)[C@H](N(C)C)C2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.37
NISCH Q9Y2I1 2/20 0.36
DHODH Q02127 1/20 0.35
HSD17B1 P14061 1/20 0.34
HSD17B2 P37059 1/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
PKM P14618 1/20 0.33
SLC9A1 P19634 1/20 0.33
ICMT O60725 1/20 0.33
ADAM10 O14672 1/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP9 P14780 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21294766 1.00 PIN1 (0.37) PIN1NISCHDHODHHSD17B1HSD17B2
SCHEMBL21296534 0.88 KMT2A (0.38) NPC1POLBMAPTMMP1MMP2
SCHEMBL21306631 0.87 KAT6A (0.37)
SCHEMBL21294667 0.82 PIN1 (0.39) PIN1NISCHDHODHNPC1RAB9A
SCHEMBL21294930 0.82 IRAK4 (0.39)
SCHEMBL21294822 0.81 AKT1 (0.38)
SCHEMBL21294804 0.80 LMNA (0.41) MEN1KMT2A
SCHEMBL21294752 0.78 PIN1 (0.35) PIN1NISCHDHODHNPC1RAB9A
SCHEMBL21294791 0.75 TAS1R3 (0.35)
SCHEMBL29482004 0.74 CTSB (0.36) POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3759098-A1 PYRIDINE-SULFONAMIDE COMPOUNDS AND THEIR USE AGAINST PAIN AND RELATED CONDITIONS Genentech, Inc. (US) 2021-01-06 EP disclosed
WO-2019165290-A1 PYRIDINE-SULFONAMIDE COMPOUNDS AND THEIR USE AGAINST PAIN AND RELATED CONDITIONS GENENTECH, INC. (US) 2019-08-29 WO disclosed